Arno Hazekamp
Overview
Explore the profile of Arno Hazekamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdel-Kader M, Radwan M, Metwaly A, Eissa I, Hazekamp A, ElSohly M
Molecules
. 2024 Mar;
29(6).
PMID: 38542886
is one of the oldest plants utilized by humans for both economic and medical purposes. Although the use of cannabis started millennia ago in the Eastern hemisphere, its use has...
2.
Abdel-Kader M, Radwan M, Metwaly A, Eissa I, Hazekamp A, Sohly M
Cannabis Cannabinoid Res
. 2023 Sep;
8(6):974-985.
PMID: 37756221
Throughout history, Cannabis has had a significant influence on human life as one of the earliest plants cultivated by humans. The plant was a source of fibers used by the...
3.
Aviram J, Atzmony D, Frenklakh A, Kroll A, Zaks I, Hazekamp A
J Cannabis Res
. 2022 Oct;
4(1):55.
PMID: 36274184
Background: Although the worldwide use of medical cannabis (MC) is on the rise, there is insufficient data regarding the long-term stability of phytocannabinoids in the plant material under different storage...
4.
Welling M, Liu L, Hazekamp A, Dowell A, King G
Med Cannabis Cannabinoids
. 2021 Oct;
2(1):1-13.
PMID: 34676328
The plant genus is a prolific producer of unique pharmaceutically relevant metabolites, commonly referred to as cannabinoids. Robust and standardised methods for the quantification of cannabinoids within botanical and drug...
5.
Hazekamp A
Med Cannabis Cannabinoids
. 2021 Oct;
1(1):65-72.
PMID: 34676324
In just a few years, cannabidiol (CBD) has become immensely popular around the world. After initially being discovered as an effective self-medication for Dravet syndrome in children, CBD is now...
6.
7.
de Hoop B, Heerdink E, Hazekamp A
Cannabis Cannabinoid Res
. 2018 Mar;
3(1):54-55.
PMID: 29588916
No abstract available.
8.
Hazekamp A
Front Pharmacol
. 2016 May;
7:108.
PMID: 27199751
In several countries with a National medicinal cannabis program, pharmaceutical regulations specify that herbal cannabis products must adhere to strict safety standards regarding microbial contamination. Treatment by gamma irradiation currently...
9.
Kowal M, van Steenbergen H, Colzato L, Hazekamp A, Van der Wee N, Manai M, et al.
Eur Neuropsychopharmacol
. 2015 Aug;
25(11):1943-53.
PMID: 26298832
Cannabis has been suggested to impair the capacity to recognize discrepancies between expected and executed actions. However, there is a lack of conclusive evidence regarding the acute impact of cannabis...
10.
Solowij N, Broyd S, van Hell H, Hazekamp A
BMC Pharmacol Toxicol
. 2014 Oct;
15:58.
PMID: 25319497
Background: Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids. Cannabidiol (CBD) has been shown to have anxiolytic and antipsychotic effects with high doses administered orally....